Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleReviewsR

Clinical Factors Associated with Treatment Outcomes Following Whole-brain Irradiation in Patients with Prostate Cancer

LIESA DZIGGEL, STEVEN E. SCHILD, THEO VENINGA, AMIRA BAJROVIC and DIRK RADES
In Vivo January 2017, 31 (1) 35-38;
LIESA DZIGGEL
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
STEVEN E. SCHILD
2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
THEO VENINGA
3Department of Radiotherapy, Dr. Bernard Verbeeten Institute, Tilburg, the Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AMIRA BAJROVIC
4Department of Radiotherapy, University Medical Center Eppendorf, Hamburg, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DIRK RADES
1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: rades.dirk@gmx.net
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 31 no. 1 35-38
PubMed 
28064217

Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received November 12, 2016
  • Revision received December 6, 2016
  • Accepted December 7, 2016
  • Published online January 7, 2017.

Copyright & Usage 
Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

Author Information

  1. LIESA DZIGGEL1,
  2. STEVEN E. SCHILD2,
  3. THEO VENINGA3,
  4. AMIRA BAJROVIC4 and
  5. DIRK RADES1⇑
  1. 1Department of Radiation Oncology, University of Lübeck, Lübeck, Germany
  2. 2Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ, U.S.A.
  3. 3Department of Radiotherapy, Dr. Bernard Verbeeten Institute, Tilburg, the Netherlands
  4. 4Department of Radiotherapy, University Medical Center Eppendorf, Hamburg, Germany
  1. Correspondence to: Professor Dirk Rades, MD, Department of Radiation Oncology, University of Lübeck, Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany. Tel: +49 4515006661, Fax: +49 4515003324, e-mail: rades.dirk{at}gmx.net
View Full Text

Cited By...

  • 9 Citations
  • Google Scholar
PreviousNext
Back to top

In this issue

In Vivo: 31 (1)
In Vivo
Vol. 31, Issue 1
January-February 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clinical Factors Associated with Treatment Outcomes Following Whole-brain Irradiation in Patients with Prostate Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
1 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Clinical Factors Associated with Treatment Outcomes Following Whole-brain Irradiation in Patients with Prostate Cancer
LIESA DZIGGEL, STEVEN E. SCHILD, THEO VENINGA, AMIRA BAJROVIC, DIRK RADES
In Vivo Jan 2017, 31 (1) 35-38;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Clinical Factors Associated with Treatment Outcomes Following Whole-brain Irradiation in Patients with Prostate Cancer
LIESA DZIGGEL, STEVEN E. SCHILD, THEO VENINGA, AMIRA BAJROVIC, DIRK RADES
In Vivo Jan 2017, 31 (1) 35-38;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Eastern Cooperative Oncology Group Performance Score Is Associated With Survival After Radiotherapy of Bone Metastases from Prostate Cancer
  • Prognostic Role of Pre-Treatment Symptoms for Survival of Patients Irradiated for Brain Metastases
  • Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer
  • Comparison of Diagnosis-specific Survival Scores for Patients With Cerebral Metastases from Malignant Melanoma Including the New WBRT-30-MM
  • Potential Impact of the Interval Between Imaging and Whole-brain Radiotherapy in Patients With Relatively Favorable Survival Prognoses
  • Whole-Brain Radiotherapy (WBRT) for Brain Metastases: Does the Interval Between Imaging and Treatment Matter?
  • Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer
  • Contribution of Patient-reported Symptoms Before Palliative Radiotherapy to Development of Multivariable Prognostic Models
  • Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases
  • Google Scholar

More in this TOC Section

  • Botulinum Toxin in the Surgical Treatment of Complex Abdominal Hernias: A Surgical Anatomy Approach, Current Evidence and Outcomes
  • Osteoid Osteoma: An Updated Review of Epidemiology, Pathogenesis, Clinical Presentation, Radiological Features, and Treatment Option
  • Robotic Total Pancreatectomy: A Narrative Review
Show more Reviews

Similar Articles

Keywords

  • prostate cancer
  • metastases to the brain
  • WBI
  • local control
  • survival
In Vivo

© 2022 In Vivo

Powered by HighWire